Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (9)

2021

  1. Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma

    Cancer Medicine, Vol. 10, Núm. 21, pp. 7585-7592

2020

  1. LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity

    Cancer Letters, Vol. 474, pp. 1-14

2018

  1. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma

    International Journal of Cancer, Vol. 143, Núm. 5, pp. 1188-1201

2017

  1. DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1

    Cancer Letters, Vol. 386, pp. 196-207

  2. DNA methylation profiling opens a new phase in the search of targeted therapy against Ewing sarcoma

    Pharmacogenomics, Vol. 18, Núm. 14, pp. 1307-1309

  3. Improved selectivity and cytotoxic effects of irinotecan via liposomal delivery: A comparative study on Hs68 and HeLa cells

    European Journal of Pharmaceutical Sciences, Vol. 109, pp. 65-77

2016

  1. Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway

    Oncotarget, Vol. 7, Núm. 35, pp. 56889-56903

2015

  1. The importance of being dead: Cell death mechanisms assessment in anti-sarcoma therapy

    Frontiers in Oncology, Vol. 5, Núm. APR

2014

  1. Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth

    Oncotarget, Vol. 5, Núm. 20, pp. 9744-9755